4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-14-000912
Options or other derivatives
- PRES./CHIEF SCIENTIFIC OFFICER acquired 200,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2014-03-19 | Other acquisition · Warrant | +50,000 | 50,000 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2014-03-19 | Other acquisition · Warrant | +150,000 | 150,000 | D | ||
Loading xslF345X03/form4-03212014_020355.xml…